JENNIFER PIPER: Open Payments
NPI 1013953215 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 20 payments from 14 companies in 2025. Trend: 2023 $131 · 2024 $394 · 2025 $531
Food & beverage: $506Education: $25
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $73 |
| Janssen Biotech, Inc. | 2 | $62 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Celgene Corporation | 2 | $48 |
| GENZYME CORPORATION | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $30 |
| Exelixis Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: ERLEADA, Enhertu, REBLOZYL, XTANDI, SARCLISA, KISQALI, Trodelvy, CABOMETYX.
Industry payments across GA — which companies pay providers there.
